Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Dax

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Idrugs : the Investigational Drugs Journal|May 10, 2008
Biapenem American Cyanamid CoS L Dax
Journal of Combinatorial Chemistry|September 11, 2001
Solid-phase Mannich condensation of amines, aldehydes, and alkynes: investigation of diverse aldehyde inputsM A Youngman, S L Dax
Current Medicinal Chemistry|April 29, 1999
Multi-component methodologies in solid-phase organic synthesisS L Dax, J J McNally, M A Youngman
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
N-acylated alpha-(3-pyridylmethyl)-beta-aminotetralin antagoinists of the human neuropeptide Y Y5 receptorJ J McNally, M A Youngman, T W Lovenberg, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2000
N-(sulfonamido)alkyl[tetrahydro-1H-benzo[e]indol-2-yl]amines: potent antagonists of human neuropeptide Y Y5 receptorJ J McNally, M A Youngman, T W Lovenberg, et al.
British Journal of Anaesthesia|July 4, 2014
GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteersJ F McLeod, J M Leempoels, S X Peng, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Aminopyrazoles with high affinity for the human neuropeptide Y5 receptorC P Kordik, C Luo, B C Zanoni, et al.
Journal of Medicinal Chemistry|May 15, 1992
Dual-action penems and carbapenemsA J Corraz, S L Dax, N K Dunlap, et al.
Journal of Medicinal Chemistry|February 12, 2000
alpha-Substituted N-(sulfonamido)alkyl-beta-aminotetralins: potent and selective neuropeptide Y Y5 receptor antagonistsM A Youngman, J J McNally, T W Lovenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2006
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216E E Codd, J R Carson, R W Colburn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Idrugs : the Investigational Drugs Journal|May 10, 2008
Biapenem American Cyanamid CoS L Dax
Journal of Combinatorial Chemistry|September 11, 2001
Solid-phase Mannich condensation of amines, aldehydes, and alkynes: investigation of diverse aldehyde inputsM A Youngman, S L Dax
Current Medicinal Chemistry|April 29, 1999
Multi-component methodologies in solid-phase organic synthesisS L Dax, J J McNally, M A Youngman
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
N-acylated alpha-(3-pyridylmethyl)-beta-aminotetralin antagoinists of the human neuropeptide Y Y5 receptorJ J McNally, M A Youngman, T W Lovenberg, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2000
N-(sulfonamido)alkyl[tetrahydro-1H-benzo[e]indol-2-yl]amines: potent antagonists of human neuropeptide Y Y5 receptorJ J McNally, M A Youngman, T W Lovenberg, et al.
British Journal of Anaesthesia|July 4, 2014
GAL-021, a new intravenous BKCa-channel blocker, is well tolerated and stimulates ventilation in healthy volunteersJ F McLeod, J M Leempoels, S X Peng, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2001
Aminopyrazoles with high affinity for the human neuropeptide Y5 receptorC P Kordik, C Luo, B C Zanoni, et al.
Journal of Medicinal Chemistry|May 15, 1992
Dual-action penems and carbapenemsA J Corraz, S L Dax, N K Dunlap, et al.
Journal of Medicinal Chemistry|February 12, 2000
alpha-Substituted N-(sulfonamido)alkyl-beta-aminotetralins: potent and selective neuropeptide Y Y5 receptor antagonistsM A Youngman, J J McNally, T W Lovenberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 13, 2006
The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216E E Codd, J R Carson, R W Colburn, et al.
Pageof 1